UPDATED Sep 09, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BCAB | US$0.71 | 59.2% | -60.6% | US$41.9m | US$10.00 | PS3.8x | E-5.0% | n/a | ||
OKUR | US$2.57 | -7.2% | n/a | US$34.8m | US$30.00 | PB0.4x | E-5.2% | n/a | ||
MSCL | CA$0.68 | 9.7% | 33.3% | CA$119.9m | CA$1.23 | PB2.3x | E-5.3% | n/a | ||
2105 | HK$15.75 | -0.8% | 264.6% | HK$6.9b | HK$26.82 | PS1190.2x | E-5.3% | n/a | ||
6628 | HK$5.70 | 12.0% | 356.0% | HK$2.2b | HK$9.44 | PS224.1x | E-5.4% | n/a | ||
GANX | US$1.71 | -10.5% | 34.6% | US$61.5m | US$7.71 | PB16.6x | E-5.4% | n/a | ||
BIOA B | SEK 285.00 | -10.1% | 63.8% | SEK 25.3b | SEK 294.60 | PE23.7x | E-5.5% | 0% | ||
INKT | US$15.36 | 10.8% | 95.8% | US$69.5m | US$39.00 | PE-6.2x | E-5.5% | n/a | ||
LTRN | US$4.05 | 0.5% | 20.9% | US$43.7m | US$22.00 | PB3.5x | E-5.9% | n/a | ||
NRIX | US$9.20 | 1.0% | -62.3% | US$703.3m | US$29.83 | PS8x | E-6.0% | n/a | ||
MRSN | US$7.66 | 9.1% | -80.6% | US$38.2m | US$28.29 | PS1.1x | E-6.2% | n/a | ||
CRVO | US$10.00 | -6.5% | -36.3% | US$92.5m | US$20.00 | PS11.9x | E-6.4% | n/a | ||
BAVA | DKK 236.40 | 0.3% | 1.6% | DKK 18.5b | DKK 244.00 | PE13x | E-6.7% | n/a | ||
ORIC | US$10.91 | 5.1% | 9.5% | US$1.1b | US$18.00 | PB3.3x | E-6.8% | n/a | ||
ANVS | US$2.36 | 1.3% | -71.8% | US$46.0m | US$13.75 | PB2.5x | E-6.8% | n/a | ||
NYKD | NOK 1.47 | -6.2% | -73.4% | NOK 480.0m | NOK 8.50 | PS6.1x | E-7.2% | 65.0% | ||
FDMT | US$6.97 | 7.7% | -55.7% | US$325.5m | US$30.40 | PS9864.1x | E-7.2% | n/a | ||
CGEM | US$6.83 | -8.8% | -61.7% | US$403.5m | US$26.22 | PB0.8x | E-7.3% | n/a | ||
ARTL | US$4.68 | -48.3% | -31.2% | US$9.2m | n/a | PE-0.9x | E-7.6% | n/a | ||
ALKS | US$27.85 | -5.3% | 3.2% | US$4.6b | US$41.59 | PE13.2x | E-7.8% | n/a | ||
RAC | AU$1.55 | 11.6% | -4.9% | AU$291.9m | AU$6.37 | PS44.4x | E-7.8% | n/a | ||
MBX | US$11.42 | -21.6% | n/a | US$383.6m | US$37.71 | PB1.7x | E-7.8% | n/a | ||
RIGL | US$35.93 | -6.6% | 179.6% | US$644.5m | US$38.33 | PE6.6x | E-7.8% | n/a | ||
KALA | US$14.00 | 14.8% | 136.9% | US$98.3m | US$21.00 | PE-2.6x | E-7.9% | n/a |